PharmaShots | Incisive News in 3 Shots

Subscribe Now

Tenaya Therapeutics

Tenaya Therapeutics Reports the First Patient Dosing of TN-201 in the P-Ib Trial (MyPeak-1) for MYBPC3-Associated Hypertrophic Cardiomyopathy

Tenaya Therapeutics Reports the First Patient Dosing of TN-201 in the P-Ib Trial (MyPeak-1) for MYBPC3-Associated Hypertrophic Car...

October 6, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us